Effect of Urethral Analgesia on Voiding

• Status: Completed
• Trial end date: 2016-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to evaluate how urethral analgesia impacts voiding efficiency in healthy women. The investigator hypothesizes that anesthetizing the urethral with lidocaine gel will decrease voiding efficiency as measured by standard bladder testing (urodynamic testing).

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Duke University
• Treatments: Lidocaine

Criteria

Inclusion Criteria:

• Females ages 18-60 years

• No health conditions as indicated in exclusion criteria

• Able to provide informed consent and agree to the risks of the study

• Willing to abstain from caffeine and alcohol for 24 hours

• Willing to avoid taking anticholinergic medications (for reasons other than incontinence; e.g., diphenhydramine) for one week prior to the procedure

Exclusion Criteria:

• Pelvic organ prolapse past the hymen

• Multiple sclerosis, myasthenia gravis, Parkinson's Disease, stroke within the past 6 months

• Interstitial cystitis / Bladder Pain Syndrome

• Recurrent (≥ 3/year) urinary tract infections

• Positive pregnancy test at the time of consent

• ≤ 6 weeks postpartum or if breastfeeding

• Positive urine dip (>+1nitrites or >1+LE) and urinary symptoms at the time of consent

• >1+ blood on urinary dip

• Morbid obesity (BMI >40)

• Taking anticholinergic medications for urinary incontinence

• >2 replies of ≥ "sometimes" on the Lower Urinary Tract Symptoms questionnaire at the time of consent